Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2010
05/26/2010CN101712675A Nitrogenous benzheterocycle derivate and application thereof to treating nervous and mental diseases
05/26/2010CN101712670A Preparation method and application of 3'8''-bis-apigenin type bis-flavonoid
05/26/2010CN101712669A Method for separating and purifying luteolin
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712658A 1-butyl-2-hydroxy aralkyl piperazine derivative and application as antidepressant
05/26/2010CN101712649A Lotus leaf extract, monomer component and application thereof
05/26/2010CN101712640A methods and compositions for treating amyloid-related diseases
05/26/2010CN101712626A Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
05/26/2010CN101712604A Selaginella pulvinata (Hook.et Grev.) Maxim. extract, extraction method and purpose
05/26/2010CN101711865A vaccine compositions containing amyloid beta1-6 antigen arrays
05/26/2010CN101711857A Film coating agent for treating whitevein and preparation method thereof
05/26/2010CN101711849A Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method
05/26/2010CN101711847A Oral traditional Chinese medicine preparation for treating melancholia and anxiety neurosis
05/26/2010CN101711843A Nerve-calming brain nourishing tea
05/26/2010CN101711834A Method for preparing medicine composition preparation of refined tuber fleeceflower preparation
05/26/2010CN101711810A Preparation used for improving sleep and enhancing immunity
05/26/2010CN101711809A Medicine composition for treating postpartum melancholia, preparation method and application
05/26/2010CN101711789A Anti-alcoholism concentrate and preparation method thereof
05/26/2010CN101711784A Preparation method of serissa serissoide extractive
05/26/2010CN101711781A Method for extracting and purifying flavonoids compounds by ion-exchange fibers
05/26/2010CN101711779A Application of Selaginella pulvinata (Hook.et Grev.) Maxim. extract in preparing medicaments for resisting Alzheimer diseases
05/26/2010CN101711752A Controlled release preparation of benzo-isoxazole derivant and preparation method thereof
05/26/2010CN101711749A Nicergoline sublingual tablet and preparation method thereof
05/26/2010CN101711739A Oral medicament combination of carbamazepine
05/26/2010CN101190322B Traditional Chinese medicine for treating zoster post herpetic neuralgia
05/26/2010CN101181486B Depression treating medicine and preparation method thereof
05/26/2010CN101129649B Traditional Chinese medicine compound formulation preparation method and uses
05/26/2010CN101111477B Benzoyl-tetrahydropyridine as glyt-1 inhibitors
05/26/2010CN101062260B Granule for complementing Yin and preventing anxiety and its production method
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101058543B Process for producing amine derivatives
05/26/2010CN101045051B Novel use of tizanidine or its derivatives in preparing medicine for prolonging fast wave sleep
05/26/2010CN101020715B Process of extracting and preparing deer nerve growth factor (DEER NGF)
05/26/2010CN101015648B Use of succinic acid derivative eater compound for treating dementia
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723334 Highly selective norepinephrine reuptake inhibitors and methods of using the same
05/25/2010US7723331 Thienopyrimidine compounds and uses thereof
05/25/2010US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example
05/25/2010CA2646779A1 Bioscience ix
05/25/2010CA2606843C Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones
05/25/2010CA2584975C Drug and food or drink for improving pancreatic functions
05/25/2010CA2522734C New polymorphs of olanzapine hydrochloride
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2469393C Processes for the measurement of the potency of glatiramer acetate
05/25/2010CA2439295C Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/25/2010CA2431761C Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2282917C Pulverulent rubber powders comprising modified fillers, processes for their preparation and their use
05/25/2010CA2273917C 3-pyridyl enantiomers and their use as analgesics
05/25/2010CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions
05/20/2010WO2010057126A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010WO2010057121A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
05/20/2010WO2010057104A2 Pyridoindole modulators of nmda receptor and acetylcholinesterase
05/20/2010WO2010057088A2 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
05/20/2010WO2010057028A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010057020A2 Modification of amyloid-beta load in non-brain tissue
05/20/2010WO2010057006A1 Azaquinolinone derivatives and uses thereof
05/20/2010WO2010056988A2 Methods of treating stroke using stem cell-like menstrual blood cells
05/20/2010WO2010056985A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056941A1 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
05/20/2010WO2010056939A1 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
05/20/2010WO2010056849A1 Gamma secretase modulators
05/20/2010WO2010056754A2 Inhibition of mammalian target of rapamycin
05/20/2010WO2010056722A1 Gamma secretase modulators
05/20/2010WO2010056672A2 Butylammonium modulators of fatty acid transport
05/20/2010WO2010056644A1 1- (ARYLSULFONYL) -4- (PI PERAZIN-I -YL) -IH-BENZ IMIDAZOLES AS δ-HYDROXYTRYPTAMINE- 6 LIGANDS
05/20/2010WO2010056622A1 TREATMENT WITH ALPHA α7-SELECTIVE LIGANDS
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010056527A2 Fused heterocyclic compounds as ion channel modulators
05/20/2010WO2010056413A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED α-SYNUCLEIN FUNCTION
05/20/2010WO2010056196A1 New compounds 578
05/20/2010WO2010056195A1 New compounds 575
05/20/2010WO2010056194A1 5h-pyrrolo [ 3, 4-b] pyridin derivatives and their use
05/20/2010WO2010056075A2 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases
05/20/2010WO2010056044A2 Novel compound acting as a vanilloid receptor antagonist, isomer or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same
05/20/2010WO2010055911A1 Biphenylacetamide derivative
05/20/2010WO2010055461A1 Method of treating sleep disorders using eplivanserin
05/20/2010WO2010055267A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
05/20/2010WO2010055260A1 Novel composition based on gamma-hydroxybutyric acid
05/20/2010WO2010055129A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055128A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055126A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055125A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055124A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010054968A1 Quinazoline derivatives as nk3 receptor antagonists
05/20/2010WO2010054485A1 Organic nutrient salts, methods of preparation and uses
05/20/2010WO2010036631A3 Sulfonyl compounds which selectively modulate the cb2 receptor
05/20/2010WO2010036630A3 Sulfonyl compounds which selectively modulate the cb2 receptor
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010WO2010025321A3 Method for treating multiple sclerosis patients with anti-il2r antibodies
1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1833